Ftse Mib
34.297,87
0,33%
DAX
19.984,50
0,38%
S&P 500
5.883,24
0,03%
NASDAQ
19.400,37
0,46%
Bitcoin
96.296,93
2,02%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Cardiff Oncology Inc (CRDF) Cardiff Oncology Inc (CRDF) Notizie

Cardiff Oncology Inc

CRDF
4,50
0,16 (3,69%)
Ultimo aggiornamento: 16:54:56
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
18/12/202422:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/12/202422:06EDGAR2Form SCHEDULE 13G - Statement of Beneficial Ownership by..
16/12/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/12/202422:10EDGAR2Form 8-K - Current report
10/12/202413:20GLOBECardiff Oncology Prices Oversubscribed $40 Million..
10/12/202412:02EDGAR2Form 8-K - Current report
10/12/202412:00GLOBECardiff Oncology Announces Positive Initial Data from..
19/11/202414:00GLOBECardiff Oncology Announces New Patent with Claims for the..
07/11/202422:05GLOBECardiff Oncology Reports Third Quarter 2024 Results and..
07/11/202422:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
30/10/202421:30GLOBECardiff Oncology Announces Journal of Clinical Oncology..
24/10/202420:02EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
08/8/202422:06EDGAR2Form 8-K - Current report
08/8/202422:05GLOBECardiff Oncology Reports Second Quarter 2024 Results and..
08/8/202422:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/8/202422:05GLOBECardiff Oncology to Report Second Quarter 2024 Results and..
17/6/202412:10EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
03/6/202422:06EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
03/6/202422:03EDGAR2Form 8-K - Current report
29/5/202422:05GLOBECardiff Oncology to Present at the Jefferies Healthcare..
13/5/202422:05GLOBECardiff Oncology to Present at Upcoming Investor Conferences..
02/5/202422:05GLOBECardiff Oncology Reports First Quarter 2024 Results and..
25/4/202422:05GLOBECardiff Oncology to Report First Quarter 2024 Results and..
08/4/202422:05GLOBECardiff Oncology Presents Novel Preclinical Data at AACR..
08/3/202400:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202400:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202400:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202400:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202422:05GLOBECardiff Oncology Announces Upcoming Presentations at the..
29/2/202422:07GLOBECardiff Oncology Reports Fourth Quarter and Full Year 2023..
29/2/202422:06GLOBECardiff Oncology Provides Clinical Update on Phase 2..
29/2/202422:05GLOBECardiff Oncology Announces First Patient Dosed in Randomized..
29/2/202422:00EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
26/2/202414:00GLOBECardiff Oncology to Present at the Cowen 44th Annual Health..
22/2/202414:00GLOBECardiff Oncology to Report Fourth Quarter and Full Year 2023..
06/2/202422:01EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
17/1/202416:30PRNUSCardiff Oncology Announces Publication of Data from Phase 1b..
08/1/202415:12EDGAR2Form 8-K - Current report
Apertura: 4,40 Min: 4,34 Max: 4,6292
Chiusura: 4,34

La tua Cronologia

NASDAQ
CRDF
Cardiff Oncology
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network